COVID-19 restrictions dent P&G’s OTC sales

22 April 2021 - Deborah Wilkes

Premium

Procter & Gamble (P&G) said worldwide sales at its Personal Health Care business had decreased by "mid-single-digits" on an organic basis in the three months ended 31 March 2021. The company has announced plans to introduce significant price increases for its Baby Care, Feminine Care and Adult Incontinence products in the US, and is assessing the need for similar moves in other categories and countries.

Click tags below for more information on topics:

Procter & Gamble COVID-19

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: